http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019203031-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7dffbd04747d5d9b9492e7f2ac61db6 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 |
| filingDate | 2019-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bad6cf5ae02e294bffbdcbc741327efd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1dd8e355ba663a590e119c1d7edcd70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2efc8b7ec477ff8c4a17a6b43742d96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bde72e4959e558a750334491714f268 |
| publicationDate | 2019-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2019203031-A |
| titleOfInvention | Irbesartan-containing pharmaceutical composition with good dissolution and orally disintegrating tablet |
| abstract | The present invention provides a pharmaceutical composition containing irbesartan exhibiting good dissolution properties. Further, the present invention is (1) can be easily manufactured with general equipment without requiring special formulation technology, (2) has an appropriate strength that does not collapse in the distribution process, and (3) promptly in the oral cavity. Disclosed is an orally disintegrating tablet containing irbesartan, which has excellent properties such as disintegration, (4) good dissolution, and (5) good taking feeling. An irbesartan-containing pharmaceutical composition comprising one or more binders selected from hydroxypropylcellulose and polyvinyl alcohol. (1) one or more disintegrants selected from D-mannitol, (2) irbesartan, (3) crospovidone and carmellose, (4) one or more binders selected from hydroxypropylcellulose and polyvinyl alcohol, and ( 5) An orally disintegrating tablet containing one or more lubricants selected from sodium stearyl fumarate and sucrose fatty acid ester. [Selection figure] None |
| priorityDate | 2019-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 85.